Infection Control Today Magazine - healthcare-acquired infections (HAIs), hospital infections, infection prevention and control, healthcare epidemiology, aseptic technique, environmental hygiene, hand hygiene, disinfection and sterilization, outbreak investigation, surveillance

FEATURES

Infection Control Tomorrow

Learn more about Infection Control Tomorrow, the industry's most progressive 2-day in-person event discussing traditional strategies and leading ...read more

Science Summit: Emerging Pathogens

The Science Summits provide an opportunity for manufacturers in the infection prevention and control arena to present and explain the science behind ...read more

Prompt Use of Antivirals is Key This Flu Season

A report published in the Jan. 16, 2015 edition of the Morbidity and Mortality Weekly Report (MMWR) estimates that this season’s flu ...read more

PPE and Ebola Preparedness

A recent increase in demand for personal protective equipment (PPE) has caused delays for some products ordered by U.S. hospitals for Ebola ...read more

Hand Hygiene Compliance Monitoring

Report Summary Hospital executives, infection preventionists and healthcare epidemiologists are by now familiar with a number of givens relating to ...read more

Latest Headlines

HIV Subtype Predicts Likelihood of Early Death from AIDS

Johns Hopkins scientists say an infected person’s HIV subtype is a better predictor than viral load for determining rapid death from AIDS. Traditional testing standards help monitor the progression of an HIV infection to AIDS by keeping track of viral load, using a scale in ...More
February 6, 2006 Posted in News
Gut Protein Found to Protect Against Infection, Intestinal Breakdown

A protein that binds to bile in the small intestine may hold the key to preventing infection and intestinal breakdown in people with conditions such as obstructive jaundice or irritable bowel syndrome, researchers at UT Southwestern Medical Center have discovered. “What ...More
February 6, 2006 Posted in News
Most Common Hepatitis C Virus Type Grown in Lab for First Time

Researchers at the University of Texas Medical Branch at Galveston (UTMB) have successfully grown the most common and damaging form of the hepatitis C virus in human liver cell cultures. This achievement — the first laboratory cultivation of a “genotype 1” hepatitis C virus ...More
February 6, 2006 Posted in News
FDA Approves New Laboratory Test to Detect Human Infections With Avian Influenza A/H5 Viruses

HHS' Food and Drug Administration (FDA) today announced the approval of a new laboratory test to diagnose H5 strains of influenza in patients suspected to be infected with the virus. The test was developed by another HHS agency, the Centers for Disease Control and ...More
February 6, 2006 Posted in News
FDA Orders Biomedical Tissue Services, Ltd., to Cease Manufacturing

Under its comprehensive framework for ensuring the safety of human tissue products, the U.S. Food and Drug Administration (FDA) today ordered Biomedical Tissue Services, Ltd. (BTS), of Fort Lee, N.J., a human tissue-recovery firm, and its CEO and executive director of ...More
February 6, 2006 Posted in News
sanofi pasteur Delivers More H5N1 Vaccine for U.S. Pandemic Initiatives

SWIFTWATER, Pa. and LYON, France -- Sanofi pasteur, the vaccines business of the sanofi-aventis Group, has delivered more H5N1 vaccine to the U.S. government including investigational doses formulated with an adjuvant. Sanofi pasteur has shipped to the U.S. National ...More
February 6, 2006 Posted in News
HHS and Institut Pasteur Partner on Pandemic Influenza Preparedness

PARIS -- The U.S. Department of Health and Human Services (HHS) and Institut Pasteur (IP) today agreed to carry out joint activities, beginning in southeast Asia, to strengthen global capacity to detect influenza viruses that could have the potential to trigger a human ...More
February 6, 2006 Posted in News
The Long Research Road to a New Vaccine

The Food and Drug Administration (FDA) today announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year. The vaccine, developed by Merck ...More
February 6, 2006 Posted in News
Rapid Diagnosis of Urinary Tract Infections with Novel Biosensor Technology

For the millions of people who suffer from urinary tract infections each year and the doctors who treat them, a promising new biosensor technology has been developed that may replace antiquated testing methods and save precious health care dollars. In a recent clinical ...More
February 3, 2006 Posted in News
Evidence Supports Call Not to Use Certain Type of Anti-viral Drugs for Flu

Recent, additional data show that the prevalence of adamantane-resistant influenza A viruses is high across the United States, according to a new study published online today by JAMA because of its public health importance. The study will be published in the Feb. 22 print ...More
February 3, 2006 Posted in News